Manufacturing as Healthcare’s Next Competitive Advantage: The Strategic Implications of Eli Lilly’s $27 Billion Investment

from Plocamium Global Insights · host James Tannahill

We’ve long recognized that manufacturing is not just an operational necessity—it is the foundation of sustainable growth, resilience, and innovation. Healthcare companies that embrace this reality will define the future of the industry. Lilly’s announcement is a powerful confirmation of this thesis.

Episode metadata supplied by the publisher feed · Published Feb 26, 2025

Embed this episode

Attribution link and audio player

Ready to play

Manufacturing as Healthcare’s Next Competitive Advantage: The Strategic Implications of Eli Lilly’s $27 Billion Investment

0:00 4:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Plocamium Global Insights?

This episode is 4 minutes long.

When was this Plocamium Global Insights episode published?

This episode was published on February 26, 2025.

Can I download this Plocamium Global Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!